Posts in tag

Immune Response


Multiple sclerosis (MS) is the most common neurological disease in young adults, affecting more than 2 million individuals worldwide, with about 1500 cases in Estonia. About 20% of MS patients experience optic neuritis (ON) as the presenting symptom, but not all ON patients develop MS. The TalTech gene technology research unit, in collaboration with the …

Reviewed by Emily Henderson, B.Sc.Aug 12 2020 Invading cells’ private space – prying into their internal functions, decisions and communications – could be a powerful tool that may help researchers develop new immunotherapy treatment for cancer. As reported today in Cell, a research group at the Weizmann Institute of Science has developed a technology that …